IRONWOOD PHARMACEUTICALS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $0 as of 2023-12-31, per its 10-K filed 2024-02-16.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2024-02-16
- 2023-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2022-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2022-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $1.43M.
- 2021-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $1.11M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-16 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-16 |
| 2022-03-31 | $1.43M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.11M 10-K · filed 2024-02-16 |
| 2021-09-30 | $7.85M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $11.26M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $11.35M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $13.06M 10-K · filed 2023-02-16 |
| 2020-09-30 | $8.25M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $16.13M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $15.85M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $31.37M 10-K · filed 2022-02-18 |
| 2019-09-30 | $11.36M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $60.72M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $50.59M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $41.02M 10-K · filed 2021-02-17 |
| 2018-09-30 | $142.77M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $159.53M 10-Q · filed 2018-08-06 |
| 2017-12-31 | $108.19M 10-K · filed 2020-02-13 |
| 2016-12-31 | $132.52M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |